The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABCAM PLC | ADS | 000380204 | 20,896 | 1,097,500 | SH | SOLE | 1,097,500 | 0 | 0 | ||
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 43,925 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 24,390 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ACCOLADE INC | COM | 00437E102 | 36,116 | 665,000 | SH | SOLE | 665,000 | 0 | 0 | ||
ACELRX PHARMACEUTICALS INC | COM | 00444T100 | 5,228 | 3,788,757 | SH | SOLE | 3,788,757 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 66,066 | 3,762,312 | SH | SOLE | 3,762,312 | 0 | 0 | ||
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 6,582 | 1,545,000 | SH | SOLE | 1,545,000 | 0 | 0 | ||
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 26,559 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 10,978 | 1,577,296 | SH | SOLE | 1,577,296 | 0 | 0 | ||
AERPIO PHARMACEUTICALS INC | COM | 00810B105 | 225 | 133,375 | SH | SOLE | 133,375 | 0 | 0 | ||
AGILON HEALTH INC | COM | 00857U107 | 283,950 | 6,999,023 | SH | SOLE | 6,999,023 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 141,870 | 2,574,308 | SH | SOLE | 2,574,308 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 13,115 | 528,601 | SH | SOLE | 528,601 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 114,715 | 187,750 | SH | SOLE | 187,750 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 26,098 | 305,706 | SH | SOLE | 305,706 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 50,856 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 18,922 | 4,320,000 | SH | SOLE | 4,320,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 9,761 | 1,012,506 | SH | SOLE | 1,012,506 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 13,879 | 535,232 | SH | SOLE | 535,232 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 9,979 | 157,900 | SH | Call | SOLE | 157,900 | 0 | 0 | |
APPLIED THERAPEUTICS INC | COM | 03828A101 | 14,581 | 701,680 | SH | SOLE | 701,680 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 39,786 | 5,248,829 | SH | SOLE | 5,248,829 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 94,837 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 48,210 | 626,100 | SH | SOLE | 626,100 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 30,717 | 233,500 | SH | SOLE | 233,500 | 0 | 0 | ||
ATAI LIFE SCIENCES NV | SHS | N0731H103 | 5,828 | 315,028 | SH | SOLE | 315,028 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 16,994 | 791,133 | SH | SOLE | 791,133 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 7,662 | 748,202 | SH | SOLE | 748,202 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 3,918 | 459,830 | SH | SOLE | 459,830 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 10,184 | 785,769 | SH | SOLE | 785,769 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 3,254 | 309,000 | SH | SOLE | 309,000 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 68,638 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 39,302 | 113,500 | SH | SOLE | 113,500 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 21,152 | 253,500 | SH | SOLE | 253,500 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 18,194 | 1,165,582 | SH | SOLE | 1,165,582 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 71,147 | 808,860 | SH | SOLE | 808,860 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 25,034 | 1,619,248 | SH | SOLE | 1,619,248 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 34,208 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
BRIGHT HEALTH GROUP INC | COM | 10920V107 | 40,755 | 2,375,000 | SH | SOLE | 2,375,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 26,054 | 1,016,945 | SH | SOLE | 1,016,945 | 0 | 0 | ||
CHIASMA INC | COM | 16706W102 | 15,411 | 3,258,144 | SH | SOLE | 3,258,144 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 9,636 | 682,449 | SH | SOLE | 682,449 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 21,749 | 920,000 | SH | SOLE | 920,000 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 10,242 | 1,236,988 | SH | SOLE | 1,236,988 | 0 | 0 | ||
CONMED CORP | COM | 207410101 | 22,332 | 162,500 | SH | SOLE | 162,500 | 0 | 0 | ||
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 8,355 | 247,200 | SH | SOLE | 247,200 | 0 | 0 | ||
COVETRUS INC | COM | 22304C100 | 39,285 | 1,455,000 | SH | SOLE | 1,455,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 27,705 | 1,075,912 | SH | SOLE | 1,075,912 | 0 | 0 | ||
CYTOKINETICS INC | NOTE 4.000%11/1 | 23282WAA8 | 16,570 | 8,000,000 | PRN | SOLE | 8,000,000 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 8,510 | 373,739 | SH | SOLE | 373,739 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 6,604 | 332,050 | SH | SOLE | 332,050 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 19,471 | 45,600 | SH | SOLE | 45,600 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 16,547 | 1,679,921 | SH | SOLE | 1,679,921 | 0 | 0 | ||
EARGO INC | COM | 270087109 | 57,870 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
EDAP TMS S A | SPONSORED ADR | 268311107 | 5,395 | 760,900 | SH | SOLE | 760,900 | 0 | 0 | ||
EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 60,278 | 582,000 | SH | SOLE | 582,000 | 0 | 0 | ||
ENCOMPASS HEALTH CORP | COM | 29261A100 | 39,015 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 25,025 | 3,011,487 | SH | SOLE | 3,011,487 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 14,372 | 503,035 | SH | SOLE | 503,035 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 2,101 | 206,000 | SH | SOLE | 206,000 | 0 | 0 | ||
EVOLENT HEALTH INC | CL A | 30050B101 | 35,884 | 1,699,043 | SH | SOLE | 1,699,043 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 70,857 | 570,000 | SH | SOLE | 570,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 6,075 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 8,327 | 312,687 | SH | SOLE | 312,687 | 0 | 0 | ||
FRESHPET INC | COM | 358039105 | 82,539 | 506,500 | SH | SOLE | 506,500 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 2,089 | 209,332 | SH | SOLE | 209,332 | 0 | 0 | ||
F-STAR THERAPEUTICS INC | COM | 30315R107 | 9,056 | 1,054,232 | SH | SOLE | 1,054,232 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 7,662 | 948,327 | SH | SOLE | 948,327 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 11,367 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
GALERA THERAPEUTICS INC | COM | 36338D108 | 5,586 | 568,252 | SH | SOLE | 568,252 | 0 | 0 | ||
GAMIDA CELL LTD | SHS | M47364100 | 13,506 | 2,107,000 | SH | SOLE | 2,107,000 | 0 | 0 | ||
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 12,585 | 15,573,000 | PRN | SOLE | 15,573,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 66,123 | 2,151,738 | SH | SOLE | 2,151,738 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 24,838 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HCA HEALTHCARE INC | COM | 40412C101 | 93,033 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
HEALTH CATALYST INC | COM | 42225T107 | 43,575 | 785,000 | SH | SOLE | 785,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,599 | 154,500 | SH | SOLE | 154,500 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 58,525 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 133,923 | 302,500 | SH | SOLE | 302,500 | 0 | 0 | ||
IDEXX LABS INC | COM | 45168D104 | 113,679 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 93,517 | 2,394,785 | SH | SOLE | 2,394,785 | 0 | 0 | ||
INNOVAGE HLDG CORP | COM | 45784A104 | 19,232 | 902,500 | SH | SOLE | 902,500 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 14,318 | 840,272 | SH | SOLE | 840,272 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 112,206 | 408,750 | SH | SOLE | 408,750 | 0 | 0 | ||
INTERSECT ENT INC | COM | 46071F103 | 20,850 | 1,220,000 | SH | SOLE | 1,220,000 | 0 | 0 | ||
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 110,357 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 77,648 | 2,302,032 | SH | SOLE | 2,302,032 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 29,725 | 448,000 | SH | SOLE | 448,000 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,050 | 206,200 | SH | SOLE | 206,200 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 44,071 | 386,618 | SH | SOLE | 386,618 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 7,719 | 331,586 | SH | SOLE | 331,586 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 17,030 | 816,800 | SH | SOLE | 816,800 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 30,387 | 626,527 | SH | SOLE | 626,527 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 12,833 | 312,618 | SH | SOLE | 312,618 | 0 | 0 | ||
LIFESTANCE HEALTH GROUP INC | COM | 53228F101 | 41,790 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 12,243 | 455,816 | SH | SOLE | 455,816 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 25,570 | 262,500 | SH | SOLE | 262,500 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 14,401 | 4,542,769 | SH | SOLE | 4,542,769 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 38,643 | 2,845,618 | SH | SOLE | 2,845,618 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 51,542 | 319,085 | SH | SOLE | 319,085 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 26,345 | 1,523,723 | SH | SOLE | 1,523,723 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 98,780 | 1,015,000 | SH | SOLE | 1,015,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | NOTE 2.250% 5/1 | 64125CAD1 | 1,347 | 1,000,000 | PRN | SOLE | 1,000,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 88,034 | 531,000 | SH | SOLE | 531,000 | 0 | 0 | ||
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 866 | 500,000 | PRN | SOLE | 500,000 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 15,780 | 497,948 | SH | SOLE | 497,948 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 96,601 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||
NOVOCURE LTD | ORD SHS | G6674U108 | 38,819 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 8,366 | 315,350 | SH | SOLE | 315,350 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 348 | 134,028 | SH | SOLE | 134,028 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 2,248 | 241,485 | SH | SOLE | 241,485 | 0 | 0 | ||
OAK STR HEALTH INC | COM | 67181A107 | 21,964 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
OLINK HLDG AB | SPONSORED ADS | 680710100 | 14,629 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
ORION ACQUISITION CORP | UNIT 02/19/2026 | 68626A207 | 9,920 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
PACIRA BIOSCIENCES INC | COM | 695127100 | 62,197 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | ||
PACIRA BIOSCIENCES INC | NOTE 2.375% 4/0 | 695127AD2 | 1,094 | 1,000,000 | PRN | SOLE | 1,000,000 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 11,285 | 1,654,714 | SH | SOLE | 1,654,714 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 40,424 | 147,500 | SH | SOLE | 147,500 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 6,859 | 1,843,764 | SH | SOLE | 1,843,764 | 0 | 0 | ||
PHREESIA INC | COM | 71944F106 | 58,848 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
POPULATION HEALTH INVS CO IN | UNIT 99/99/9999 | G71716123 | 2,041 | 201,044 | SH | SOLE | 201,044 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 2,903 | 289,754 | SH | SOLE | 289,754 | 0 | 0 | ||
PPD INC | COM | 69355F102 | 31,111 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
PRELUDE THERAPEUTICS INC | COM | 74065P101 | 10,947 | 382,359 | SH | SOLE | 382,359 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 14,640 | 596,096 | SH | SOLE | 596,096 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 6,755 | 693,542 | SH | SOLE | 693,542 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 48,844 | 950,091 | SH | SOLE | 950,091 | 0 | 0 | ||
PULMONX CORP | COM | 745848101 | 26,141 | 592,500 | SH | SOLE | 592,500 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 1,393 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 16,475 | 450,258 | SH | SOLE | 450,258 | 0 | 0 | ||
RENEO PHARMACEUTICALS INC | COM | 75974E103 | 10,534 | 1,129,024 | SH | SOLE | 1,129,024 | 0 | 0 | ||
RETROPHIN INC | NOTE 2.500% 9/1 | 761299AB2 | 2,765 | 3,250,000 | PRN | SOLE | 3,250,000 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 11,871 | 606,280 | SH | SOLE | 606,280 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 20,636 | 4,754,900 | SH | SOLE | 4,754,900 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 17,861 | 403,270 | SH | SOLE | 403,270 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 25,557 | 328,750 | SH | SOLE | 328,750 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 39,470 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 9,088 | 313,499 | SH | SOLE | 313,499 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 41,741 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 19,833 | 1,018,658 | SH | SOLE | 1,018,658 | 0 | 0 | ||
SPERO THERAPEUTICS INC | COM | 84833T103 | 13,484 | 965,928 | SH | SOLE | 965,928 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 17,992 | 1,605,001 | SH | SOLE | 1,605,001 | 0 | 0 | ||
TELEFLEX INCORPORATED | COM | 879369106 | 52,233 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
TEMPEST THERAPEUTICS INC | COM | 87978U108 | 3,468 | 310,161 | SH | SOLE | 310,161 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 9,983 | 687,500 | SH | SOLE | 687,500 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | NOTE 3.250%11/0 | 88339KAA0 | 1,429 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
TRANSLATE BIO INC | COM | 89374L104 | 19,093 | 693,266 | SH | SOLE | 693,266 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 21,800 | 1,494,164 | SH | SOLE | 1,494,164 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 6,096 | 628,500 | SH | SOLE | 628,500 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | UNIT 10/08/2025 | G9127T116 | 2,072 | 206,000 | SH | SOLE | 206,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 44,338 | 465,000 | SH | SOLE | 465,000 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 96,106 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 58,011 | 962,826 | SH | SOLE | 962,826 | 0 | 0 | ||
WEST PHARMACEUTICAL SVSC INC | COM | 955306105 | 10,234 | 28,500 | SH | SOLE | 28,500 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 10,660 | 572,500 | SH | SOLE | 572,500 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 179,468 | 1,014,000 | SH | SOLE | 1,014,000 | 0 | 0 |